- Research classification
- growth-hormone-releasing-hormone analogue research peptide
Authoritative sources
- https://pubmed.ncbi.nlm.nih.gov/16352683/
- https://pubmed.ncbi.nlm.nih.gov/34665524/
- https://pubmed.ncbi.nlm.nih.gov/30489688/
CJC-1295 nomenclature covers related growth-hormone-releasing-hormone analogues, while “No DAC” distinguishes a formulation from the long-acting drug-affinity-complex design discussed in some papers. That distinction matters scientifically. LiveWire links the broader literature but does not publish the generic CJC-1295 PubChem record as an exact identifier for this No-DAC product.
Verified reference scope
This record separates authoritative compound references from LiveWire product and batch documentation. Chemical fields describe the cited reference record and do not certify a product batch, formulation, salt state, purity, or fill.
Authoritative references
- Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults., The Journal of clinical endocrinology and metabolism (2006). PMID 16352683.
- Advances in the detection of growth hormone releasing hormone synthetic analogs., Drug testing and analysis (2021). PMID 34665524.
- An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma., Drug testing and analysis (2019). PMID 30489688.
Related products
Use the related-product links on this record to review currently published strength or formulation listings. Different strengths and blends remain separate products.
Research Use Only
This information is provided for laboratory research context only and is not medical, dosing, preparation, or administration guidance.